Showing results (1991-2000 of 2,175) with videos related to
Sort By:
Pageof 218
Journal of the American Heart Association|December 12, 2018
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER TrialLeo Ungar, Robert M Clare, Fatima Rodriguez, et al.Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
Attuning to a changing oceanNils Chr Stenseth, Mark R Payne, Erik Bonsdorff, et al.JACC. Heart Failure|October 11, 2020
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction StudyJustin A Ezekowitz, Christopher M O'Connor, Richard W Troughton, et al.JACC. Heart Failure|October 10, 2015
Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)Justin L Grodin, Antonio L Perez, Yuping Wu, et al.Circulation. Heart Failure|October 8, 2025
Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA SubstudyPalak Shah, Yinggan Zheng, Burkert Pieske, et al.Journal of Cardiac Failure|January 12, 2023
Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker SubstudyChristopher R Defilippi, Wendimagegn G Alemayehu, Adriaan A Voors, et al.Journal of the American College of Cardiology|July 5, 2005
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changesCheuk-Kit Wong, John K French, Philip E G Aylward, et al.American Heart Journal|June 5, 2017
Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularizationAnthony J Dalby, Shmuel Gottlieb, Derek D Cyr, et al.Circulation|May 16, 2007
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric CardiologyKaren P Alexander, L Kristin Newby, Paul W Armstrong, et al.American Heart Journal|September 29, 2014
Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)William Schuyler Jones, Pierluigi Tricoci, Zhen Huang, et al.Pageof 218